دانشگاه علوم پزشکی ایران
Iran University of Medical Sciences

Iran to produce 10 biotech drugs in two years

 | Post date: 2015/06/20 | 

 

TEHRAN (ISNA) - Secretary of Iranian Biotechnology Research Institute Mostafa Ghanei said the country plans to produce 10 biotechnology medicines in the next two years.

“We expect to see 10 locally-made biotechnological products in international markets in the next two years,” he said.

He further noted that 160 biotechnological products are found in global markets, and 27 of which could be available in Iran in the next two years.

According to Ghanei, Iranian drug producers have managed to sell their products in international markets.

“We aim to send home-made biotechnological products to global markets,” he noted.

Iran’s pharmaceutical market experienced a sharp growth last year, rising to $1.2 billion. There are as many as 65 pharmaceutical companies in the country, but their operations are basically limited to local formulation.

In recent years, Iranian private companies have started production of biological pharmaceuticals. The country has also a relatively advanced herbal medical basis thanks to its vast floral resources.

The pharmaceutical industry is regulated by the government, where production and importation of drugs is heavily subsidized.

While making them accessible and affordable, the state oversight has entailed in trafficking of drugs into Iran’s neighbors as well as emergence of black market and hoarding.

Collected by: Samira Homayounfard

 




CAPTCHA
View: 4983 Time(s)   |   Print: 738 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)